John A Orwin Insider Trading $RTRX Travere Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John A Orwin.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John A Orwin. John A Orwin is in ARRAY BIOPHARMA INC ($ARRY) and Director in ARRAY BIOPHARMA INC ($ARRY) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in NeurogesX Inc ($NGSX) and President & CEO in Relypsa Inc ($RLYP) and Director in Retrophin, Inc. ($RTRX) and President & CEO in Atreca, Inc. ($BCEL).
John A Orwin in Travere Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John A Orwin: Director
Holdings: 11,875 shares
Current Value: $238,331
Latest Transaction: May 19 2020
$RTRX Market Capitalization: $766.34M
$RTRX Previous Close: $20.07
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of John A Orwin in Travere Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARRY, BCEL, NGSX, RLYP, SGEN, RTRX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 19 2020 | RTRX | Retrophin, Inc. | Orwin John A | Director | Option Exercise | A | 15.43 | 9,000 | 138,870 | 9,000 | |
| May 19 2020 | RTRX | Retrophin, Inc. | Orwin John A | Director | Grant | A | 0.00 | 3,000 | 0 | 11,875 | 8.9 K to 11.9 K (+33.80 %) |
| May 10 2019 | RTRX | Retrophin, Inc. | Orwin John A | Director | Option Exercise | A | 17.94 | 8,000 | 143,520 | 8,000 | |
| May 10 2019 | RTRX | Retrophin, Inc. | Orwin John A | Director | Grant | A | 0.00 | 2,000 | 0 | 8,875 | 6.9 K to 8.9 K (+29.09 %) |
| May 11 2018 | RTRX | Retrophin, Inc. | Orwin John A | Director | Option Exercise | A | 26.52 | 10,000 | 265,200 | 10,000 | |
| May 11 2018 | RTRX | Retrophin, Inc. | Orwin John A | Director | Grant | A | 0.00 | 2,500 | 0 | 6,875 | 4.4 K to 6.9 K (+57.14 %) |
| Mar 27 2017 | RTRX | Retrophin, Inc. | Orwin John A | Director | Option Exercise | A | 17.53 | 17,500 | 306,775 | 17,500 | |
| Mar 27 2017 | RTRX | Retrophin, Inc. | Orwin John A | Director | Grant | A | 0.00 | 4,375 | 0 | 4,375 | 0 to 4.4 K |
Page: 1